Free Trial

Prudential Financial Inc. Buys Shares of 28,185 Ardent Health Partners, LLC (NYSE:ARDT)

Ardent Health Partners logo with Medical background

Prudential Financial Inc. acquired a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 28,185 shares of the company's stock, valued at approximately $481,000.

A number of other institutional investors have also recently bought and sold shares of ARDT. US Bancorp DE bought a new position in Ardent Health Partners during the fourth quarter valued at about $31,000. Bank of New York Mellon Corp boosted its holdings in Ardent Health Partners by 8.2% in the 4th quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock valued at $438,000 after purchasing an additional 1,941 shares during the period. R Squared Ltd acquired a new stake in Ardent Health Partners during the fourth quarter worth about $37,000. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners during the 3rd quarter worth approximately $42,000. Finally, New York State Common Retirement Fund bought a new stake in Ardent Health Partners in the 4th quarter valued at $48,000.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Truist Financial cut their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Guggenheim began coverage on Ardent Health Partners in a research note on Wednesday, April 9th. They issued a "buy" rating and a $16.00 price target on the stock. Mizuho lowered their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Stephens reissued an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a report on Tuesday, April 1st. Finally, Morgan Stanley reduced their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Ardent Health Partners has an average rating of "Buy" and a consensus target price of $20.58.

Read Our Latest Research Report on ARDT

Ardent Health Partners Price Performance

Shares of Ardent Health Partners stock traded up $0.01 during midday trading on Tuesday, reaching $12.43. The company had a trading volume of 42,483 shares, compared to its average volume of 452,652. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The stock has a fifty day simple moving average of $13.81 and a 200 day simple moving average of $15.70. Ardent Health Partners, LLC has a 1-year low of $11.60 and a 1-year high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. Equities research analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Ardent Health Partners Company Profile

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines